PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,597 | -94.8% | 10,026 | -92.5% | 0.00% | – |
| Q2 2023 | $126,407 | -51.9% | 134,290 | -51.0% | 0.00% | – |
| Q1 2023 | $262,731 | -47.5% | 274,335 | -24.4% | 0.00% | -100.0% |
| Q4 2022 | $500,598 | +5.6% | 362,752 | -4.3% | 0.00% | 0.0% |
| Q3 2022 | $474,000 | -44.6% | 379,136 | +4.6% | 0.00% | 0.0% |
| Q2 2022 | $855,000 | -8.3% | 362,356 | +20.5% | 0.00% | 0.0% |
| Q1 2022 | $932,000 | +8.0% | 300,732 | +121.3% | 0.00% | 0.0% |
| Q4 2021 | $863,000 | – | 135,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |